参考文献/References:
[1] 胡盛寿,高润霖,刘力生,等. 《中国心血管病报告2018》概要 [J].中国循环杂志,2019,34(3):209-220.
[2] Harikrishnan S. Diet,the gut microbiome and heart failure[J]. Card Fail Rev,2019,5(2):119-122.
[3] Houghton D,Stewart CJ,Day CP,et al. Gut microbiota and lifestyle interventions in NAFLD[J]. Int J Mol Sci,2016,17(4):447-475.
[4] Espin JC. Gut microbiota, diet and health. (We and our gut microbes) [J]. Mol Nutr Food Res,2017,61(1):1770015.
[5] Zhu W,Gregory JC,Org E,et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk[J]. Cell,2016,165(1):111-124.
[6] Rath S,Heidrich B,Pieper DH,et al. Uncovering the trimethylamine-producing bacteria of the human gut microbiota[J]. Microbiome,2017,5(1):54-67.
[7] Senthong V,Wang Z,Fan Y,et al. Trimethylamine N-oxide and mortality risk in patients with peripheral artery disease[J]. J Am Heart Assoc,2016,5(10):e004237.
[8] Senthong V,Li XS,Hudec T,et al. Plasma trimethylamine N-oxide, a gut microbe-generated phosphatidylcholine metabolite, is associated with atherosclerotic burden[J]. J Am Coll Cardiol,2016,67(22):2620-2628.
[9] Randrianarisoa E,Lehn-Stefan A,Wang X,et al. Relationship of serum trimethylamine N-oxide (TMAO) levels with early atherosclerosis in humans[J]. Sci Rep,2016,6:26745.
[10] Haghikia A,Li XS,Liman TG,et al. Gut microbiota-dependent trimethylamine N-oxide predicts risk of cardiovascular events in patients with stroke and is related to proinflammatory monocytes[J]. Arterioscler Thromb Vasc Biol,2018,38(9):2225-2235.
[11] Geng J,Yang C,Wang B,et al. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway[J]. Biomed Pharmacother,2018,97:941-947.
[12] Ding L,Chang M,Guo Y,et al. Trimethylamine-N-oxide(TMAO)-induced atherosclerosis is associated with bile acid metabolism[J]. Lipids Health Dis,2018,17(1):286-293.
[13] Cho CE, Taesuwan S, Malysheva OV, et al. Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: a randomized controlled trial[J]. Mol Nutr Food Res,2017,61(1):1600324.
[14] Yazdekhasti N,Brandsch C,Schmidt N,et al. Fish protein increases circulating levels of trimethylamine-N-oxide and accelerates aortic lesion formation in apoE null mice[J]. Mol Nutr Food Res,2016,60(2):358-368.
[15] Aldana-Hernandez P,Leonard KA,Zhao YY,et al. Dietary choline or trimethylamine N-oxide supplementation does not influence atherosclerosis development in Ldlr-/- and Apoe-/- male mice[J]. J Nutr,2019,Sep 16.pii: nxz214. DOI: 10.1093/jn/nxz214. [Epub ahead of print].
[16] Romano KA,Vivas EI,Amador-Noguez D,et al. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide [J]. mBio,2015,6(2):e02481.
[17] Oellgaard J,Winther SA,Hansen TS,et al. Trimethylamine N-oxide(TMAO) as a new potential therapeutic target for insulin resistance and cancer[J]. Curr Pharm Des,2017,23(25):3699-3712.
[18] Dambrova M, Skapare-Makarova E, Konrade I, et al. Meldonium decreases the diet-increased plasma levels of trimethylamine N-oxide, a metabolite associated with atherosclerosis[J]. J Clin Pharmacol,2013,53(10):1095-1098.
[19] Wang Z, Roberts AB, Buffa JA, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis[J]. Cell,2015,163(7):1585-1595.
[20] Li X, Sun Y, Zhang X, et al. Reductions in gut microbiota-derived metabolite trimethylamine N-oxide in the circulation may ameliorate myocardial infarction-induced heart failure in rats, possibly by inhibiting interleukin-8 secretion [J]. Mol Med Rep,2019,20(1):779-786.
[21] Chen PY,Li S,Koh YC,et al. Oolong tea extract and citrus peel polymethoxyflavones reduce transformation of l-carnitine to trimethylamine-N-oxide and decrease vascular inflammation in l-carnitine feeding mice[J]. J Agric Food Chem,2019,67(28):7869-7879.
[22] Chen ML,Yi L,Zhang Y,et al. Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota[J]. mBio,2016,7(2):e02210-02215.
[23] Chekalina NI. Resveratrol has a positive effect on parameters of central hemodynamics and myocardial ischemia in patients with stable coronary heart disease [J]. Wiad Lek,2017,70(2 pt 2):286-291.
[24] Shi Y,Hu J,Geng J,et al. Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice[J]. Biomed Pharmacother,2018,107:1556-1563.
[25] Wan Q,Liu Z,Yang Y,et al. Suppressive effects of berberine on atherosclerosis via downregulating visfatin expression and attenuating visfatin-induced endothelial dysfunction[J]. Int J Mol Med,2018,41(4):1939-1948.
[26] 王波,陈翔,史承勇. 益生菌对稳定性冠心病患者血清TMAO水平的影响及与血清炎性因子水平的相关性[J].中国微生态学杂志,2019,31(5):556-559,563.
[27] Qiu L,Yang D,Tao X,et al. Enterobacter aerogenes ZDY01 attenuates choline-induced trimethylamine n-oxide levels by remodeling gut microbiota in mice[J]. J Microbiol Biotechnol,2017,27(8):1491-1499.
[28] 杨娟,王佑华,苑素云.肠道菌群与血管内炎症[J].心血管病学进展,2016, 37(3):263-267.
[29] Tenore GC,Caruso D,Buonomo G,et al. Lactofermented annurca apple puree as a functional food indicated for the control of plasma lipid and oxidative amine levels: results from a randomised clinical trial[J]. Nutrients,2019,11(1):122-136.
[30] Heianza Y,Ma W,Manson JE,et al. Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies[J]. J Am Heart Assoc,2017,6(7):e004947.
[31] Troseid M,Ueland T,Hov JR,et al. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure[J]. J Intern Med,2015,277(6):717-726.
[32] Schuett K,Kleber ME,Scharnagl H,et al. Trimethylamine-N-oxide and heart failure with reduced versus preserved ejection fraction[J]. J Am Coll Cardiol,2017,70(25):3202-3204.
[33] Organ CL,Otsuka H,Bhushan S,et al. Choline diet and its gut microbe-derived metabolite, trimethylamine N-oxide, exacerbate pressure overload-induced heart failure[J]. Circ Heart Fail,2016,9(1):e002314.
[34] Chioncel O,Ambrosy AP. Trimethylamine N-oxide and risk of heart failure progression:marker or mediator of disease[J]. Eur J Heart Fail,2019,21(7):887-890.
[35] Li Z,Wu Z,Yan J,et al. Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis[J]. Lab Invest,2019,99(3):346-357.
[36] Sun G,Yin Z, Liu N,et al. Gut microbial metabolite TMAO contributes to renal dysfunction in a mouse model of diet-induced obesity[J]. Biochem Biophys Res Commun,2017,493(2):964-970.
[37] Savi M,Bocchi L,Bresciani L,et al. Trimethylamine-N-oxide (TMAO)-induced impairment of cardiomyocyte function and the protective role of urolithin B-glucuronide[J]. Molecules,2018,23(3):549-560.
[38] Makrecka-Kuka M,Volska K,Antone U,et al. Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria[J]. Toxicol Lett,2017,267:32-38.
[39] Suzuki T,Yazaki Y,Voors AA,et al. Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure:results from BIOSTAT-CHF[J]. Eur J Heart Fail,2019,21(7):877-886.
[40] Liu Z,Ma Z,Zhang H,et al. Ferulic acid increases intestinal Lactobacillus and improves cardiac function in TAC mice[J]. Biomed Pharmacother,2019,120:109482.
[41] Zhou GF,Jiang YH,Ma DF,et al. Xiao-Qing-Long Tang prevents cardiomyocyte hypertrophy, fibrosis, and the development of heart failure with preserved ejection faction in rats by modulating the composition of the gut microbiota[J]. Biomed Res Int,2019,2019:9637479.
相似文献/References:
[1]杨娟,综述,王佑华,等.肠道菌群与血管内炎症[J].心血管病学进展,2016,(3):263.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.012]
YANG Juan,WANG Youhua,YUAN Suyun.Relationship Between Gut Microbiota and Vascular Inflammation[J].Advances in Cardiovascular Diseases,2016,(3):263.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.012]
[2]张琪 宋晓鹏 任茂佳 吴广 赵兴胜.氧化三甲胺与心血管疾病的研究新进展[J].心血管病学进展,2020,(1):81.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.022]
ZHANG Qi,SONG Xiaopeng,REN Maojia,et al.Trimethylamine Oxide and Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(3):81.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.022]
[3]赵霄潇 颜红兵.三甲胺-N-氧化物在心血管相关疾病发病机制中的研究进展[J].心血管病学进展,2020,(11):1123.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
Cardiovascular Related Diseases.Research Progress of Trimethylamine-N-oxide in Pathogenesis of[J].Advances in Cardiovascular Diseases,2020,(3):1123.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[4]王猛 江洪.肠道菌群及其代谢产物与心房颤动的研究进展[J].心血管病学进展,2022,(3):214.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
WANG Meng,JIANG Hong.Gut Microbiota an d Its Metabolites in Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(3):214.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[5].肠-脑轴与心血管疾病的研究进展[J].心血管病学进展,2022,(7):595.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
TAN Wuping,W ANG Meng,ZHOU Xiaoya.Gut-Brain Axis and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2022,(3):595.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[6]刘杏利 高中山 段豪亮 赵奕 马玉兰.肠道菌群及其代谢物与心律失常关系的研究进展[J].心血管病学进展,2022,(11):1002.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.009]
LIU Xingli,GAO Zhongshan,DUAN Haoliang,et al.The Relationship Between Intestinal Flora and Its Metabolites and Arrhythmia[J].Advances in Cardiovascular Diseases,2022,(3):1002.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.009]
[7]张嘉原 张莉.果糖代谢与血脂异常的研究进展[J].心血管病学进展,2022,(12):1114.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.013]
ZHANG Jiayuan ZHANG Li.Fructose Metabolism and DyslipidemiaA Systematic Review[J].Advances in Cardiovascular Diseases,2022,(3):1114.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.013]
[8]卢燕 刘亚萍 罗强 张全波 汪汉.肠道菌群及其代谢物与痛风[J].心血管病学进展,2023,(2):177.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.018]
LU Yan,LIU Yaping,LUO Qiang,et al.Intestinal Flora and Its Metabolites and Gout[J].Advances in Cardiovascular Diseases,2023,(3):177.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.018]
[9]蒋振江 刘富强 王军奎.肠道菌群与肥胖的关系研究进展[J].心血管病学进展,2023,(3):265.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.017]
JIANG Zhenjiang,LIU Fuqiang,WANG Junkui.The Relationship Between Gut Microbiota and Obesity[J].Advances in Cardiovascular Diseases,2023,(3):265.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.017]
[10]李帅 刘富强 王军奎.酒精摄入对肠道菌群的影响及其机制研究进展[J].心血管病学进展,2023,(2):172.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.017]
LI ShuaiLIU FuqiangWANG Junkui.Effects of Alcohol Intake on Intestinal Flora and Its Mechanism[J].Advances in Cardiovascular Diseases,2023,(3):172.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.017]